SII Adar Poonawalla Speaks About Monkeypox Vaccine In India
As monkeypox cases are rising in India, the Serum Institute of India (SII) which manufactured the Covid-19 vaccine, spoke about the possibility of a monkeypox vaccine in India. SII CEO Adar Poonawalla said, "We are talking to Novovax. We really need to see whether there will be a lot of demand or whether in three to four months it fizzles out." Moreover, he ruled out manufacturing from scratch amid time issues.